» Articles » PMID: 25464856

The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8(+) T Cells During Chronic Infection

Overview
Journal Immunity
Publisher Cell Press
Date 2014 Dec 4
PMID 25464856
Citations 219
Authors
Affiliations
Soon will be listed here.
Abstract

Protein kinase B (also known as AKT) and the mechanistic target of rapamycin (mTOR) are central regulators of T cell differentiation, proliferation, metabolism, and survival. Here, we show that during chronic murine lymphocytic choriomeningitis virus infection, activation of AKT and mTOR are impaired in antiviral cytotoxic T lymphocytes (CTLs), resulting in enhanced activity of the transcription factor FoxO1. Blockade of inhibitory receptor programmed cell death protein 1 (PD-1) in vivo increased mTOR activity in virus-specific CTLs, and its therapeutic effects were abrogated by the mTOR inhibitor rapamycin. FoxO1 functioned as a transcriptional activator of PD-1 that promoted the differentiation of terminally exhausted CTLs. Importantly, FoxO1-null CTLs failed to persist and control chronic viral infection. Collectively, this study shows that CTLs adapt to persistent infection through a positive feedback pathway (PD-1?FoxO1?PD-1) that functions to both desensitize virus-specific CTLs to antigen and support their survival during chronic viral infection.

Citing Articles

Transferrin Disassociates TCR from CD3 Signaling Apparatus to Promote Metastasis.

Cheng R, Tang X, Zhao Q, Wang Y, Chen W, Wang G Research (Wash D C). 2025; 8():0578.

PMID: 39810853 PMC: 11731779. DOI: 10.34133/research.0578.


Phenotypic and spatial heterogeneity of CD8 tumour infiltrating lymphocytes.

Sun Y, Yinwang E, Wang S, Wang Z, Wang F, Xue Y Mol Cancer. 2024; 23(1):193.

PMID: 39251981 PMC: 11382426. DOI: 10.1186/s12943-024-02104-w.


A Complex Interplay of Tumor Microenvironment Could Enhance Cholangiocarcinoma Progression Even After Surgery: A Prospective Study.

Zahran A, Rayan A, Saad K, Rezk K, Soliman A, Rizk M J Clin Med Res. 2024; 16(7-8):363-374.

PMID: 39206103 PMC: 11349130. DOI: 10.14740/jocmr5201.


FBXO22 promotes osteosarcoma progression via regulation of FOXO1 for ubiquitination and degradation.

Zhang H, Bai Y, Li J, Chen T, Shang G J Cell Mol Med. 2024; 28(16):e70021.

PMID: 39153212 PMC: 11330286. DOI: 10.1111/jcmm.70021.


ACLY and ACSS2 link nutrient-dependent chromatin accessibility to CD8 T cell effector responses.

Kaymak I, Watson M, Oswald B, Ma S, Johnson B, DeCamp L J Exp Med. 2024; 221(9).

PMID: 39150482 PMC: 11329787. DOI: 10.1084/jem.20231820.


References
1.
Chang C, Curtis J, Maggi Jr L, Faubert B, Villarino A, OSullivan D . Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 2013; 153(6):1239-51. PMC: 3804311. DOI: 10.1016/j.cell.2013.05.016. View

2.
Lu P, Youngblood B, Austin J, Mohammed A, Butler R, Ahmed R . Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection. J Exp Med. 2014; 211(3):515-27. PMC: 3949569. DOI: 10.1084/jem.20130208. View

3.
Speiser D, Utzschneider D, Oberle S, Munz C, Romero P, Zehn D . T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion?. Nat Rev Immunol. 2014; 14(11):768-74. DOI: 10.1038/nri3740. View

4.
Biggs 3rd W, Meisenhelder J, Hunter T, Cavenee W, Arden K . Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci U S A. 1999; 96(13):7421-6. PMC: 22101. DOI: 10.1073/pnas.96.13.7421. View

5.
Parry R, Chemnitz J, Frauwirth K, Lanfranco A, Braunstein I, Kobayashi S . CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol. 2005; 25(21):9543-53. PMC: 1265804. DOI: 10.1128/MCB.25.21.9543-9553.2005. View